157 related articles for article (PubMed ID: 37272441)
21. Review article: exploring the link between Helicobacter pylori and gastric cancer.
Kuipers EJ
Aliment Pharmacol Ther; 1999 Mar; 13 Suppl 1():3-11. PubMed ID: 10209681
[TBL] [Abstract][Full Text] [Related]
22. Expression of TFF2 and Helicobacter pylori infection in carcinogenesis of gastric mucosa.
Hu GY; Yu BP; Dong WG; Li MQ; Yu JP; Luo HS; Rang ZX
World J Gastroenterol; 2003 May; 9(5):910-4. PubMed ID: 12717829
[TBL] [Abstract][Full Text] [Related]
23. [Intestinal metaplasia and Helicobacter pylori infection, their relationship and effects of eradication therapy].
Sakaki N; Kozawa H
Nihon Rinsho; 2001 Feb; 59(2):361-6. PubMed ID: 11218413
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.
Ito M; Haruma K; Kamada T; Mihara M; Kim S; Kitadai Y; Sumii M; Tanaka S; Yoshihara M; Chayama K
Aliment Pharmacol Ther; 2002 Aug; 16(8):1449-56. PubMed ID: 12182744
[TBL] [Abstract][Full Text] [Related]
25. hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis.
Vidal AF; Cruz AM; Magalhães L; Pereira AL; Anaissi AK; Alves NC; Albuquerque PJ; Burbano RM; Demachki S; Ribeiro-dos-Santos Â
World J Gastroenterol; 2016 Feb; 22(6):2060-70. PubMed ID: 26877610
[TBL] [Abstract][Full Text] [Related]
26. Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection.
Zub-Pokrowiecka A; Rembiasz K; Konturek SJ; Budzynski A; Konturek PC; Budzynski P
Med Sci Monit; 2010 Oct; 16(10):CR493-500. PubMed ID: 20885354
[TBL] [Abstract][Full Text] [Related]
27. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
[TBL] [Abstract][Full Text] [Related]
28. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
[TBL] [Abstract][Full Text] [Related]
29. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
30. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
Kapadia CR
J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
[TBL] [Abstract][Full Text] [Related]
31. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?
Meining A; Morgner A; Miehlke S; Bayerdörffer E; Stolte M
Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):983-98. PubMed ID: 11866488
[TBL] [Abstract][Full Text] [Related]
32. Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication.
Iacopini F; Consolazio A; Bosco D; Marcheggiano A; Bella A; Pica R; Paoluzi OA; Crispino P; Rivera M; Mottolese M; Nardi F; Paoluzi P
Helicobacter; 2003; 8(5):503-12. PubMed ID: 14535997
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
34. [Changes of gastric mucosa histopathology after Helicobacter pylori eradication].
Zhou LY; Shen ZY; Lin SR; Jin Z; Ding SG; Huang XB; Xia ZW; Liu JJ; Guo HL; William C
Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):162-4. PubMed ID: 12816696
[TBL] [Abstract][Full Text] [Related]
35. Gastric Intestinal Metaplasia: An Intermediate Precancerous Lesion in the Cascade of Gastric Carcinogenesis.
Malik TH; Sayahan MY; Al Ahmed HA; Hong X
J Coll Physicians Surg Pak; 2017 Mar; 27(3):166-172. PubMed ID: 28406776
[TBL] [Abstract][Full Text] [Related]
36. Long-term sequelae of Helicobacter pylori gastritis.
Kuipers EJ; Uyterlinde AM; Peña AS; Roosendaal R; Pals G; Nelis GF; Festen HP; Meuwissen SG
Lancet; 1995 Jun; 345(8964):1525-8. PubMed ID: 7791437
[TBL] [Abstract][Full Text] [Related]
37. Gastric mucosal precancerous lesions in
Yu M; Ma J; Song XX; Shao QQ; Yu XC; Khan MN; Qi YB; Hu RB; Wei PR; Xiao W; Jia BL; Cheng YB; Kong LF; Chen CL; Ding SZ
World J Gastroenterol; 2022 Jul; 28(28):3682-3694. PubMed ID: 36161049
[TBL] [Abstract][Full Text] [Related]
38. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
39. High expression of Helicobacter pylori VapD in both the intracellular environment and biopsies from gastric patients with severity.
Morales-Espinosa R; Delgado G; Serrano LR; Castillo E; Santiago CA; Hernández-Castro R; Gonzalez-Pedraza A; Mendez JL; Mundo-Gallardo LF; Manzo-Merino J; Ayala S; Cravioto A
PLoS One; 2020; 15(3):e0230220. PubMed ID: 32163505
[TBL] [Abstract][Full Text] [Related]
40. Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia.
Ohkuma K; Okada M; Murayama H; Seo M; Maeda K; Kanda M; Okabe N
J Gastroenterol Hepatol; 2000 Oct; 15(10):1105-12. PubMed ID: 11106088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
